Webinars and Sponsored Roundtables — Register Now

Wednesday, September 23, 2026. 12 PM-1 PM ET
Roundtable presenters Dr. David Sacks MB, ChB, FRCPath, Chairman, Steering Committee National Glycohemoglobin Standardization Program (NGSP), and Priya Sivaraman, PhD, Senior Technical Product Manager, Tosoh Bioscience

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Thursday, September 24, 2026 11 AM-12 PM CT
This session explores the evolving role of RAS in precision oncology, from the biology of RAS mutations to the expanding landscape of targeted therapies. Through expert presentations, real-world case discussions, and interactive audience polling, participants will examine best practices for RAS biomarker testing across solid tumors, including lung, colorectal, and pancreatic cancers. The session will highlight practical considerations for tissue and liquid biopsy, strategies to address testing gaps, and the importance of multidisciplinary collaboration to ensure timely identification of patients who may benefit from RAS-targeted therapies.

Webinar presenters David Braxton, MD, Chief of Molecular Pathology Services, Hoag Family Cancer Institute & Hoag Memorial Hospital Presbyterian, and Carlos Becerra, MD, Research Director for Medical Oncology, Margaret Given Larkin Endowed Chair for Developmental Cancer Therapeutics, Hoag Memorial Hospital Presbyterian

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, September 30, 2026. 1 PM-1:30 PM ET
Roundtable presenters John Longshore, PhD, Head of Scientific Affairs, Global Oncology Diagnostics, AstraZeneca, and Flora Berisha, MS, Executive Director, Global Head of Diagnostic Partnering and Development, Johnson & Johnson Innovative Medicine, and Mark D. Ewalt, MD, Associate Medical Director for Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, and Isabel Preeshagul, DO, MBS, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Thursday, October 1, 2026 1 PM-2 PM ET
This presentation will explore the value of in-house CGP, offer insights into the benefits and drawbacks of incorporation, and provide information about important practical factors when considering in-house implementation of CGP.

Webinar presenter Allison M. Cushman-Vokoun, MD, PhD, FCAP, Medical Director, Molecular Diagnostics and Personalized Medicine Laboratory, Director, Division of Diagnostic Molecular Pathology and Human Genetics, Henry F. Krous Professor of Pathology, University of Nebraska Medical Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, October 20, 2026 11 AM-12 PM ET
Hear experts review the biological and clinical significance of the HER2 expression continuum in breast tissue, providing a clearer understanding of how these variations might impact diagnosis, and discuss the emerging importance of documenting HER2-low and HER2-ultralow categories using a validated IHC assay.

Webinar presenters Keith Wharton, MD, PhD, Global Medical Affairs Leader–Pathology, Roche Diagnostics Solutions, and Hannah Y. Wen, MD, PhD, Director, Breast Pathology Fellowship, Associate Team Leader, Breast Pathology Team, Attending Pathologist, Memorial Sloan Kettering Cancer Center

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Marketplace Directory

CMOS cameras, software, 10/17

October 2017—sCMOS, with Sony’s Pregius CMOS sensor. The RT sCMOS is optimal for fluorescence microscopy, fluorescent in situ hybridization, green fluorescent protein (GFP) imaging, immunofluorescence, and 3-D deconvolution applications. Features include deep cooling, which allows dim images to be seen without becoming obscured by dark current; a global shutter, which ensures undistorted images of moving specimens; and 5 megapixel live and captured image resolution. The sCMOS is nine times more sensitive than the previous RT camera.

Grifols, Beckman Coulter form distribution agreement, 10/17

October 2017—Grifols and Beckman Coulter have entered into an exclusive, long-term agreement for the global distribution of Grifols’ hemostasis instruments, reagents, and consumables. The companies anticipate first commercializing systems under this agreement in Europe in early 2018.

Vitros insulin assay gets FDA clearance, 10/17

October 2017—Ortho Clinical Diagnostics announced that its Vitros Immunodiagnostic Products Insulin Reagent and Calibrators have received FDA clearance and the CE mark. The assay is expected to be commercially available for use on all of the company’s Vitros immunodiagnostic and integrated systems in Europe, in other countries accepting the CE mark, and in the U.S. during the third quarter of this year.

MALDI-TOF MS microbiology document, 10/17

October 2017—The Clinical and Laboratory Standards Institute has published a microbiology guideline, “M58: Methods for the Identification of Cultured Microorganisms Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry, 1st ed.”

Baebies partners with Labsystems, 10/17

October 2017—Baebies, a Durham, NC–based company focused on advancing newborn screening and pediatric testing, has signed a bilateral distribution agreement with Trivitron’s Labsystems Diagnostics to deliver newborn screening solutions to several markets worldwide. Baebies will distribute Labsystems’ newborn screening products NeoMass AAAC and NS 2400 in the United States after obtaining regulatory clearance.

Thermo Scientific leakproof vials, 10/17

October 2017—Thermo Scientific Samco Clicktainer leakproof vials have been developed to provide sample protection and user safety by enabling correct cap application. The vials are designed for the secure collection and handling of fluid, solid, and powder samples, including urine, sputum, and stool specimens; the lid-lock design makes them ideal for the secure transport of clinical, research, and forensic samples.

PerkinElmer, IDG team up for WGS program , 10/17

October 2017—PerkinElmer is collaborating with In-Depth Genomics to support IDG’s whole genome sequencing diagnostic program, which will bring genetic diagnosis to patients who have a wide range of neurological conditions, including orphan disorders, and aims to provide improved diagnoses and treatments.

Ambry, NorthShore to offer genetic testing, 10/17

October 2017—Ambry Genetics and NorthShore University HealthSystem’s Center for Personalized Medicine (Evanston, Ill.) will partner to offer genetic testing and research to advance precision medicine in preventive care.

FDA-cleared BioPlex assay, 10/17

October 2017—Bio-Rad Laboratories announced FDA clearance for its BioPlex 2200 ToRC IgM Assay, a fully automated assay for the detection of IgM class antibodies to Toxoplasma gondii, rubella, and cytomegalovirus offered in a multiplexed panel.